Pathologic myopia: where are we now?
- PMID: 12429239
- DOI: 10.1016/s0002-9394(02)01883-4
Pathologic myopia: where are we now?
Abstract
Purpose: To describe current concepts and available treatments for pathologic myopia.
Design: Review of experimental and clinical studies.
Methods: The demography, natural history, medical and surgical treatments for choroidal neovascular membrane, vitreoretinal interface disorders and future strategies for pathologic myopia are reviewed.
Results: Several medical and surgical modalities are currently available to treat various complications of pathologic myopia. Macular translocation appears to stabilize or improve visual function in many eyes with choroidal neovascularization.
Conclusion: Newer strategies are emerging to better ameliorate or prevent the complications of pathologic myopia.
Similar articles
-
Recent trends in the management of maculopathy secondary to pathological myopia.Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):3-13. doi: 10.1007/s00417-011-1889-0. Epub 2011 Dec 13. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 22159713 Review.
-
Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization: a clinicopathologic case report.Retina. 2002 Dec;22(6):818-24. doi: 10.1097/00006982-200212000-00027. Retina. 2002. PMID: 12476118 No abstract available.
-
Lacquer cracks following laser treatment of choroidal neovascularization in pathologic myopia.Retina. 1998;18(2):118-24. doi: 10.1097/00006982-199818020-00004. Retina. 1998. PMID: 9564691
-
[Morphological features of myopic choroidal neovascularization: differences to neovascular age-related macular degeneration].Ophthalmologe. 2012 Aug;109(8):749-57. doi: 10.1007/s00347-011-2498-3. Ophthalmologe. 2012. PMID: 22911352 German.
-
Choroidal Neovascularization Secondary to Myopia, Infection and Inflammation.Dev Ophthalmol. 2016;55:167-75. doi: 10.1159/000431194. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26501802 Review.
Cited by
-
Recent trends in the management of maculopathy secondary to pathological myopia.Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):3-13. doi: 10.1007/s00417-011-1889-0. Epub 2011 Dec 13. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 22159713 Review.
-
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients.BMC Ophthalmol. 2020 Oct 19;20(1):414. doi: 10.1186/s12886-020-01679-4. BMC Ophthalmol. 2020. PMID: 33076864 Free PMC article.
-
Inflammatory cytokines in highly myopic eyes.Sci Rep. 2019 Mar 5;9(1):3517. doi: 10.1038/s41598-019-39652-x. Sci Rep. 2019. PMID: 30837544 Free PMC article.
-
Various cross-linking methods inhibit the collagenase I degradation of rabbit scleral tissue.BMC Ophthalmol. 2020 Dec 14;20(1):488. doi: 10.1186/s12886-020-01751-z. BMC Ophthalmol. 2020. PMID: 33317477 Free PMC article.
-
Effects of timing of vitrectomy performed for open-globe injury patients on the thickness of retinal nerve fiber layer.Pak J Med Sci. 2015 Jan-Feb;31(1):100-4. doi: 10.12669/pjms.311.6088. Pak J Med Sci. 2015. PMID: 25878623 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources